Conjugated Linoleic Acid: Uses, Fat Loss, and Safety

Conjugated linoleic acid, usually called CLA, is a naturally occurring fat found mainly in meat and dairy from cattle, sheep, and goats. It gained popularity as a weight-loss supplement in the early 2000s, and it still lines shelves at supplement stores today. The reality backed by clinical trials is more modest: across multiple meta-analyses, CLA supplementation produces roughly half a kilogram to about one kilogram of extra fat loss compared to placebo, an amount researchers themselves describe as clinically uncertain in significance. The story gets more interesting when you look at why the effects are so small, what the two main forms of CLA actually do inside the body, and why some of CLA’s side effects raise more concern than the fat-loss benefit warrants enthusiasm.

Two Isomers That Do Very Different Things

CLA is not one molecule. It refers to a family of fatty acids that share a particular chemical backbone but differ in the exact position of their double bonds. Two isomers dominate the conversation. The first, called cis-9, trans-11 CLA (often shortened to c9,t11), is the form found most abundantly in food, especially dairy fat and ruminant meat. The second, called trans-10, cis-12 CLA (t10,c12), is the one that shows up in much higher proportions in supplements and is responsible for most of the fat-related effects people associate with CLA.

Lab studies on human fat cell precursors show that the t10,c12 isomer reduces the uptake of glucose and fat into cells and blocks the process by which immature fat cells become mature ones. It does this partly by lowering the expression of a key regulatory protein called PPARγ, which acts as a master switch for fat cell development.¹ The c9,t11 isomer, by contrast, actually increased the expression of that same protein in the same experiments, pushing cells toward fat storage rather than away from it. Separate research in mouse fat cells confirmed that the t10,c12 isomer also stimulated fat burning and energy expenditure to a greater degree than c9,t11.²

Work on human fat tissue reinforces the distinction. When researchers treated cultures of human stromal vascular cells with increasing concentrations of t10,c12 CLA, triglyceride content dropped steadily. The same experiment with c9,t11 CLA or plain linoleic acid did the opposite: fat content rose.³ This helps explain why a supplement containing a roughly equal mix of both isomers does not produce the dramatic fat loss that t10,c12 alone causes in animal studies: the c9,t11 isomer may partially counteract it.

Where CLA Comes From Naturally

CLA forms inside the digestive systems of ruminant animals. Bacteria in the rumen, including species of Propionibacterium, Lactobacillus, and Lactococcus, convert linoleic acid from the animal’s diet into CLA through a process called biohydrogenation.⁴ The details of that bacterial conversion depend on a surprising number of environmental factors. Free-floating bacteria in the rumen produce more CLA than bacteria attached to feed particles, and the cow’s own diet, the amount of fat in the feed, and even incubation time all influence how much CLA accumulates.⁵

How the cow is fed matters for the consumer, too. Grass-fed beef contains higher concentrations of CLA isomers and trans-vaccenic acid (a precursor the body can convert into CLA) compared to grain-fed beef on a fat-by-fat basis.⁶ Dairy products follow a similar pattern: milk from pastured cows tends to be richer in CLA than milk from grain-fed herds. Even so, the total amount of CLA a person gets from food is typically well below what supplement trials use, generally a few hundred milligrams per day from diet versus three to six grams in most studies.

Humans can also make a small amount of CLA internally. A study in lactating women showed that some of the c9,t11 CLA found in breast milk was endogenously produced from trans-vaccenic acid using a desaturase enzyme, though this internal conversion accounted for less than ten percent of the CLA present in the milk.⁷

How Supplements Are Made

CLA supplements are not extracted from beef or butter. They are manufactured by chemically converting linoleic acid from plant oils, typically safflower or soybean oil, using alkaline catalysts.⁸ The result is usually a roughly equal mix of the c9,t11 and t10,c12 isomers, which is quite different from what you would get from food. Natural dairy fat is heavily dominated by the c9,t11 form, while supplements deliver a much larger dose of the t10,c12 isomer that drives fat-metabolism changes. This distinction matters because the two isomers have different effects throughout the body, and most safety concerns in the literature trace back specifically to t10,c12.

What the Evidence Actually Says About Fat Loss

Two large meta-analyses of randomized controlled trials paint a consistent picture. One, pooling data from trials of at least six months, found that CLA supplementation produced an average of about 0.7 kilograms more weight loss and about 1.3 kilograms more fat loss than placebo in overweight and obese people. The authors concluded that the clinical relevance of these effects was uncertain.⁹ A second meta-analysis, with a broader set of trials, found roughly half a kilogram of additional weight loss, about 0.6 kilograms of extra fat loss, and a small gain in lean body mass of about 0.2 kilograms. Again, the authors described the practical effect as not clinically considerable.¹⁰

So the effect is real in a statistical sense. People taking CLA do lose slightly more fat than people taking a placebo. But the magnitude is tiny. Half a kilogram to a kilogram of extra fat loss over several months is not something most people would notice, and it is well within the range of normal daily weight fluctuation. For context, simply reducing calorie intake modestly or adding a few extra walks per week would dwarf that effect.

The Mouse Problem and Metabolic Side Effects

If you only read mouse studies, CLA looks like a miracle compound. Mice fed CLA lose massive amounts of body fat, sometimes dramatically so. But this is where the story takes a less appealing turn. In mice, CLA (particularly the t10,c12 isomer) causes something researchers call a lipoatrophic syndrome: the fat tissue shrinks rapidly, but the liberated fat has to go somewhere, and much of it ends up in the liver. The result is severe fatty liver, hyperinsulinemia, and insulin resistance.¹¹

Mice are unusually sensitive to this effect. A review of CLA research across species found that the severe fatty liver response is most dramatic in mice, with a more muted version in other animals. However, the underlying pattern held across species: when CLA reduced body fat, liver fat tended to increase, suggesting the liver absorbs mobilized fatty acids faster than it can burn or export them.¹² In human trials, the doses used are much lower relative to body weight than in mouse studies, and the liver effects have been far less alarming. But the pattern is a genuine concern that has not been fully resolved, and it is one reason researchers remain cautious about recommending long-term supplementation.

Effects on Blood Lipids

Heart health is another area where CLA’s reputation outpaces the evidence. A large dose-response meta-analysis pooling 56 randomized controlled trials found that CLA supplementation did not meaningfully change triglycerides, total cholesterol, LDL cholesterol, or apolipoprotein levels. It did produce a small but statistically significant decrease in HDL cholesterol, which is the type you generally want to keep up, not push down.¹³ That is not a reassuring finding for a supplement marketed partly on cardiovascular grounds.

A smaller trial in obese adults did find reductions in total cholesterol, LDL cholesterol, and non-HDL cholesterol with CLA supplementation, but it also showed an increase in triglycerides and a worrying rise in the atherogenic index of plasma, a composite measure of cardiovascular risk.¹⁴ The picture, in other words, is mixed. CLA does not appear to reliably improve cardiovascular risk markers, and it may worsen some of them. For people already managing cholesterol or heart disease risk, this is worth knowing before adding CLA to the regimen.

Energy Expenditure and Fat Burning Pathways

One of the ways the t10,c12 isomer seems to work at a cellular level is by nudging the body toward burning more fat for fuel. In mice, CLA increased levels of uncoupling proteins, particularly UCP2 in white fat tissue and UCP3 protein in skeletal muscle. Uncoupling proteins essentially let cells “waste” energy as heat rather than storing it, which could contribute to the fat-loss effect.¹⁵ Separate work found that t10,c12 CLA improved endurance exercise capacity in mice by promoting fat oxidation during exercise and sparing stored glycogen, potentially through a mechanism involving a fat-metabolism regulator called PPARδ.¹⁶

These findings are often cited in supplement marketing, but the disconnect between animal and human outcomes is stark. In mice, these metabolic shifts are large enough to produce visible fat loss. In humans, they appear to be too small relative to total energy expenditure to make a practical difference in body composition, which is consistent with the underwhelming meta-analysis results.

CLA and Exercise Performance in Humans

Given the animal data on fat oxidation, it is natural to wonder whether CLA gives athletes or gym-goers a meaningful edge. The evidence says no, at least for the people most likely to be taking it. A study in experienced resistance-trained athletes found that CLA supplementation did not significantly change body mass, fat-free mass, fat mass, body fat percentage, bone mass, or strength during training.¹⁷ A separate trial in resistance-trained athletes of varying experience did observe a small reduction in body fat alongside CLA use, but lean mass gains were not statistically significant.¹⁸

One population where a combination supplement looked more promising was older adults. When CLA was combined with creatine monohydrate alongside supervised resistance training over six months, the combination group showed greater improvements in muscular endurance, knee extension strength, and lean mass than exercise alone.¹⁹ Because the supplement contained both creatine and CLA, it is hard to attribute the benefits to CLA specifically, and creatine has a much stronger track record in strength and lean mass research.

Inflammation and Immune Effects

CLA has shown anti-inflammatory activity in animal models. In weaned pigs challenged with a bacterial toxin, dietary CLA reduced the production of pro-inflammatory signaling molecules like IL-6 and TNF-α while increasing the expression of the anti-inflammatory molecule IL-10. Both CLA isomers suppressed inflammation in isolated immune cells, though the t10,c12 isomer was the more potent of the two. The anti-inflammatory action appeared to work through the same PPARγ pathway involved in fat metabolism.²⁰

One small human study offered an intriguing finding on the immune front: a 50:50 mixture of CLA isomers appeared to improve the early immune response to hepatitis B vaccination in healthy men, though the effect was not seen with a CLA supplement that was 80 percent c9,t11.²¹ These are early and limited findings, not the basis for treating CLA as an immune supplement, but they hint that the isomer balance matters for immune outcomes just as it does for fat metabolism.

Bone Health

Preclinical research suggests that the t10,c12 isomer can enhance bone mineral density by promoting bone formation and slowing bone breakdown.²² Cell-culture work has shown that CLA can increase markers of bone building activity, and mouse studies found that t10,c12 CLA maintained higher bone mineral density during aging by influencing the balance between bone-forming and bone-resorbing cells and reducing fat accumulation in the bone marrow.²³

However, a study in ovariectomized rats, a standard model for postmenopausal bone loss, found that CLA supplementation had no effect on bone mineral density or calcium absorption.²⁴ The discrepancy between that result and the more encouraging cell-culture and mouse-aging studies is unresolved. Human trials on CLA and bone outcomes are scarce. For now, bone health remains a theoretical benefit, not a demonstrated one.

Effects on Gut Bacteria

A finding that has generated some interest among researchers is CLA’s effect on the gut microbiome. In mice fed a high-fat diet, CLA supplementation significantly increased populations of Bacteroides/Prevotella and Akkermansia muciniphila, a bacterium that has been linked in other research to better metabolic health and leaner body composition. The increase in Akkermansia was particularly dramatic compared to both normal-fat and high-fat control groups.²⁵ Whether this happens in humans at typical supplement doses, and whether it contributes to any measurable health outcome, remains open.

Why Dairy Farmers Pay Attention to CLA

CLA has a practical life outside of supplement bottles: it is a significant concern in dairy science. When certain dietary conditions cause higher levels of t10,c12 CLA to appear in a cow’s system, the result is milk fat depression, a drop in the fat content of the milk. This happens because t10,c12 CLA suppresses the expression of genes responsible for fat synthesis in the mammary gland, including those encoding acetyl-CoA carboxylase and fatty acid synthase.²⁶ A recent transcriptomic analysis found that CLA’s effects in dairy cows extended beyond the mammary gland, altering gene expression in the liver and subcutaneous fat tissue as well, affecting fatty acid metabolism, the PPAR signaling pathway, and insulin-related pathways.²⁷

For dairy farmers, milk fat depression is usually a problem to be managed, not a benefit. It reduces the economic value of the milk. But for researchers, the dairy cow has become an important model for understanding how CLA regulates fat metabolism across tissues, and some of the clearest evidence for the mechanism of t10,c12 CLA has come from this agricultural work rather than from human trials.

Safety and the Unresolved Questions

A definitive conclusion on CLA’s long-term safety in humans has not been reached. A comprehensive review noted that the safety profile depends on which isomer or combination of isomers is used, the dose, how long someone takes it, the form of the supplement, and characteristics of the person taking it, including age, sex, and ethnic background.²⁸ The t10,c12 isomer’s tendency to shunt fat toward the liver, the small but unwelcome drop in HDL cholesterol, and the insulin-resistance findings in mice all warrant caution. In the United States, certain CLA preparations have GRAS (generally recognized as safe) status for use in foods and supplements, but this is not the same as a regulatory endorsement of long-term efficacy or safety at high doses.

For someone considering CLA, the honest takeaway is that the fat-loss effect is too small to justify the supplement on its own, the side-effect profile is murky rather than clean, and the most promising biological effects seen in labs and animal studies have not translated into clear wins in human trials. The CLA in a steak or a glass of whole milk is not going to hurt you, and grass-fed products deliver somewhat more of it, but chasing those extra milligrams with high-dose supplements is a bet on very thin evidence.